Stryker Other Stockholder Equity vs Common Stock Shares Outstanding Analysis
SYK Stock | USD 329.08 3.06 0.92% |
Stryker financial indicator trend analysis is much more than just breaking down Stryker prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Stryker is a good investment. Please check the relationship between Stryker Other Stockholder Equity and its Common Stock Shares Outstanding accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stryker. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.
Other Stockholder Equity vs Common Stock Shares Outstanding
Other Stockholder Equity vs Common Stock Shares Outstanding Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Stryker Other Stockholder Equity account and Common Stock Shares Outstanding. At this time, the significance of the direction appears to have strong relationship.
The correlation between Stryker's Other Stockholder Equity and Common Stock Shares Outstanding is 0.74. Overlapping area represents the amount of variation of Other Stockholder Equity that can explain the historical movement of Common Stock Shares Outstanding in the same time period over historical financial statements of Stryker, assuming nothing else is changed. The correlation between historical values of Stryker's Other Stockholder Equity and Common Stock Shares Outstanding is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Stockholder Equity of Stryker are associated (or correlated) with its Common Stock Shares Outstanding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock Shares Outstanding has no effect on the direction of Other Stockholder Equity i.e., Stryker's Other Stockholder Equity and Common Stock Shares Outstanding go up and down completely randomly.
Correlation Coefficient | 0.74 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Other Stockholder Equity
Common Stock Shares Outstanding
The total number of shares of a company's common stock that are currently owned by all its shareholders.Most indicators from Stryker's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Stryker current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stryker. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.At this time, Stryker's Selling General Administrative is quite stable compared to the past year. Enterprise Value is expected to rise to about 116.9 B this year, although the value of Tax Provision will most likely fall to about 289.7 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 11.0B | 11.6B | 13.1B | 13.7B | Total Revenue | 17.1B | 18.4B | 20.5B | 21.5B |
Stryker fundamental ratios Correlations
Click cells to compare fundamentals
Stryker Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Stryker fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 30.2B | 34.3B | 34.6B | 36.9B | 39.9B | 41.9B | |
Short Long Term Debt Total | 10.2B | 13.2B | 12.5B | 13.0B | 13.0B | 13.6B | |
Other Current Liab | 2.9B | 3.5B | 3.4B | 3.7B | 3.9B | 4.1B | |
Total Current Liabilities | 4.4B | 5.0B | 4.5B | 6.3B | 7.9B | 8.3B | |
Total Stockholder Equity | 12.8B | 13.1B | 14.9B | 16.6B | 18.6B | 19.5B | |
Property Plant And Equipment Net | 2.6B | 2.8B | 2.8B | 3.0B | 3.2B | 3.4B | |
Net Debt | 5.9B | 10.3B | 9.5B | 11.2B | 10.0B | 10.5B | |
Retained Earnings | 11.7B | 12.5B | 13.5B | 14.8B | 16.8B | 17.6B | |
Cash | 4.3B | 2.9B | 2.9B | 1.8B | 3.0B | 3.1B | |
Non Current Assets Total | 18.8B | 24.6B | 24.6B | 26.6B | 27.4B | 28.8B | |
Non Currrent Assets Other | 1.4B | 2.0B | 2.2B | 2.4B | 2.7B | 2.8B | |
Cash And Short Term Investments | 4.4B | 3.0B | 3.0B | 1.9B | 3.1B | 1.7B | |
Net Receivables | 2.9B | 2.7B | 3.0B | 3.6B | 3.8B | 4.0B | |
Liabilities And Stockholders Equity | 30.2B | 34.3B | 34.6B | 36.9B | 39.9B | 41.9B | |
Non Current Liabilities Total | 13.0B | 16.2B | 15.2B | 14.0B | 13.4B | 14.1B | |
Inventory | 3.3B | 3.5B | 3.3B | 4.0B | 4.8B | 5.1B | |
Other Current Assets | 760M | 488M | 662M | 787M | 857M | 520.6M | |
Other Stockholder Equity | 1.6B | 1.7B | 1.9B | 2.0B | 2.2B | 2.3B | |
Total Liab | 17.4B | 21.2B | 19.8B | 20.3B | 21.3B | 22.4B | |
Total Current Assets | 11.4B | 9.7B | 10.0B | 10.3B | 12.5B | 13.1B | |
Short Term Debt | 859M | 761M | 7M | 1.2B | 2.1B | 2.2B | |
Intangible Assets | 4.2B | 5.6B | 4.8B | 4.9B | 4.6B | 4.8B | |
Accounts Payable | 675M | 810M | 1.1B | 1.4B | 1.5B | 1.6B | |
Property Plant And Equipment Gross | 2.6B | 2.8B | 5.5B | 5.8B | 6.3B | 6.7B | |
Accumulated Other Comprehensive Income | (606M) | (1.2B) | (531M) | (221M) | (416M) | (395.2M) | |
Short Term Investments | 88M | 81M | 75M | 84M | 82M | 77.9M | |
Good Will | 9.1B | 12.8B | 12.9B | 14.9B | 15.2B | 16.0B | |
Other Liab | 2.4B | 3.0B | 2.7B | 1.8B | 2.0B | 1.1B | |
Other Assets | 2.6B | 3.5B | 4.0B | 3.9B | 4.5B | 4.7B | |
Long Term Debt | 10.2B | 13.2B | 12.5B | 11.9B | 10.9B | 11.4B | |
Property Plant Equipment | 2.6B | 2.8B | 2.8B | 3.0B | 3.4B | 3.6B | |
Net Tangible Assets | (489M) | (5.2B) | (2.9B) | (3.1B) | (2.8B) | (2.7B) | |
Retained Earnings Total Equity | 11.7B | 12.5B | 13.5B | 14.8B | 17.0B | 10.2B | |
Capital Surpluse | 1.6B | 1.7B | 1.9B | 2.0B | 2.3B | 1.5B | |
Non Current Liabilities Other | 2.7B | 3.0B | 1.8B | 1.5B | 1.9B | 1.8B | |
Accumulated Depreciation | (2.1B) | (2.4B) | (2.7B) | (2.8B) | (2.6B) | (2.7B) |
Currently Active Assets on Macroaxis
When determining whether Stryker is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Stryker Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Stryker Stock. Highlighted below are key reports to facilitate an investment decision about Stryker Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stryker. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Complementary Tools for Stryker Stock analysis
When running Stryker's price analysis, check to measure Stryker's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stryker is operating at the current time. Most of Stryker's value examination focuses on studying past and present price action to predict the probability of Stryker's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Stryker's price. Additionally, you may evaluate how the addition of Stryker to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
CEOs Directory Screen CEOs from public companies around the world | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |
Is Stryker's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stryker. If investors know Stryker will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stryker listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.331 | Dividend Share 3.1 | Earnings Share 8.76 | Revenue Per Share 55.173 | Quarterly Revenue Growth 0.097 |
The market value of Stryker is measured differently than its book value, which is the value of Stryker that is recorded on the company's balance sheet. Investors also form their own opinion of Stryker's value that differs from its market value or its book value, called intrinsic value, which is Stryker's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stryker's market value can be influenced by many factors that don't directly affect Stryker's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stryker's value and its price as these two are different measures arrived at by different means. Investors typically determine if Stryker is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stryker's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.